Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Return on Assets (2022 - 2025)

Prime Medicine's Return on Assets history spans 4 years, with the latest figure at 0.56% for Q4 2025.

  • For Q4 2025, Return on Assets rose 6.0% year-over-year to 0.56%; the TTM value through Dec 2025 reached 0.56%, up 6.0%, while the annual FY2025 figure was 0.64%, 16.0% up from the prior year.
  • Return on Assets reached 0.56% in Q4 2025 per PRME's latest filing, up from 0.6% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.41% in Q1 2023 to a low of 0.92% in Q4 2023.
  • Average Return on Assets over 4 years is 0.64%, with a median of 0.65% recorded in 2025.
  • Peak YoY movement for Return on Assets: crashed -49bps in 2023, then increased 29bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 0.42% in 2022, then tumbled by -116bps to 0.92% in 2023, then soared by 32bps to 0.62% in 2024, then rose by 9bps to 0.56% in 2025.
  • Per Business Quant, the three most recent readings for PRME's Return on Assets are 0.56% (Q4 2025), 0.6% (Q3 2025), and 0.66% (Q2 2025).